Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03258593
Brief Title: Durvalumab and Vicinium in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

First Submitted : August 22, 2017
First Submitted that Met QC Criteria : August 22, 2017
First Posted : August 23, 2017

Last Update Submitted that Met QC Criteria : May 8, 2019
Last Update Posted : May 9, 2019